Literature data suggest that elevated blood values of IL-18 and IL-18 Binding Protein and alterations in their ratio may be significantly correlated with various autoinflammatory diseases, such as systemic juvenile idiopathic arthritis, recurrent autoinflammatory fevers etc. In this view, the clinical implication of this observational, prospective, single-centre, non-pharmacological study will be the definition of new laboratory markers that may be useful in the early differential diagnosis of certain rare and serious paediatric diseases.
Age between 2 years and 18 years;
Being affected by 1 of the following: Juvenile Idiopathic Arthritis; recurrent fever/ autoinflammatory disease; rheumatic disease; severe infectious diseases (sepsis, meningitis, urinary tract infection, lower respiratory tract infection);
Obtaining informed consent from parents/legal guardians of paediatric patients.
None
The study enrolls patients referred to the Pediatric Rheumatology Outpatient Clinic of the Pediatrics Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Italy, for suspected Juvenile Idiopathic Arthritis or suspected recurrent fever/self-inflammatory disease.
Cohort
Prospective
Not listed
Serum levels of IL-18, and IL-18BP
pg/mL
Serum levels of inflammatory cytokines
IL-6; IL-8; TNF alpha; IL-12p70; IL-1 beta; IL-10 (pg/mL)
Serum levels of acute phase proteins
C-reactive protein (mg/dL); amyloid A protein (mg/dL); ferritin (ng/dL); transferrin (mg/dL); fibrinogen (mg/dL)
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
